INNOVATE Corp. (NYSE: VATE)

Innovate Corp., known by its stock symbol VATE, is a diversified holding company with a range of subsidiaries operating in various segments. Its primary business activities are carried out through three reportable segments: Infrastructure, Life Sciences, and Spectrum, along with an Other segment.

The Infrastructure segment, the most significant contributor to the company's revenue, is managed by DBM Global Inc. (DBMG), a fully integrated construction company that offers a variety of services such as design-assist, modularization, fabrication, and erection of structural steel, heavy steel plate, trusses, and girders. DBMG caters to numerous commercial and industrial market segments, including high-rise buildings, office complexes, hotels, and casinos. The company operates 14 fabrication shops across the United States and 32 sales and management facilities globally.

DBMG's strategy emphasizes achieving a leading position in the geographic regions and project segments it serves by providing timely, high-quality services to its customers. This is pursued through design-assist, design-build, and pre-construction services, as well as the ability to offer a wide range of services over a vast geographical area.

The Life Sciences segment is run by Pansend Life Sciences, LLC, a subsidiary dedicated to supporting healthcare and biotechnology product development. Its strategy revolves around delivering innovative solutions to its customers through design-assist, design-build, and pre-construction services.

The Spectrum segment is operated by HC2 Broadcasting Holdings Inc. and its subsidiaries, a strategic operator of Over-The-Air (OTA) broadcasting stations throughout the United States, including Puerto Rico. The company's strategy in this segment aims at expanding operations through strategic acquisitions and partnerships.

In the Infrastructure segment, DBM Global offers services such as design-assist, modularization, fabrication, and erection of structural steel, heavy steel plate, trusses, and girders. These services are provided through 14 fabrication shops in the United States and 32 sales and management facilities worldwide.

In the Life Sciences segment, Pansend Life Sciences focuses on supporting healthcare and biotechnology product development. It maintains controlling interests in Genovel Orthopedics, Inc., which develops novel partial and total knee replacements for the treatment of osteoarthritis of the knee, and R2 Technologies, Inc., which develops aesthetic and medical technologies for the skin.

The Spectrum segment includes HC2 Broadcasting Holdings Inc. and its subsidiaries, which own and operate broadcast TV stations across the United States. The company's strategy in this segment is geared towards growing its operations through strategic acquisitions and partnerships.

Innovate Corp. operates in a highly competitive industry with numerous established players and new entrants striving for market share. The company's competitive advantages include its strong relationships with customers, its ability to offer a variety of services across a broad geography, and its focus on providing high-quality services to its customers.

The company's customers are diverse, including national and multi-national construction and engineering firms, national and regional accounts, original equipment manufacturers, industrial owners, and other customers. The majority of DBMG's business is conducted in North America, though the company also operates in other regions such as Australia, Canada, India, New Zealand, the Philippines, and the UK.

In the Life Sciences segment, the company's products compete favorably due to several competitive factors. These include the products' ability to safely downregulate inflammation and pain, accelerate exfoliation and normalize melanin production. Additionally, the products offer versatile treatment capabilities for patients of all ages and skin types and achieve measurable results with little to no patient discomfort and high patient satisfaction.

In the Spectrum segment, the company's broadcast TV stations compete for audience share and advertising revenue with other broadcast TV stations and cable networks.